Acute Intermittent Porphyria Market to Receive Overwhelming Hike in Revenues by 2026
Acute intermittent porphyria (AIP) is a hereditary metabolic disorder. It affects the production of heme, which is the prosthetic group of hemoglobin binding to oxygen. It is caused due to low enzyme porphobilinogen deaminase. The main reasons for acute intermittent porphyria are insomnia, anorexia, and change in coloration of urine, myalgia, and retention of urine. At times, AIP results in the formation of liver tumor (hepatocellular carcinoma) and kidney failure. Some of the symptoms also mention issues related to gastrointestinal...
View full press release